SYS-CON MEDIA Authors: Bob Gourley, Greg Schulz, Sandi Mappic, Don Nelson, Gilad Parann-Nissany

News Feed Item

Global Drug-eluting Stent Market 2014-2018

DUBLIN, April 25, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tz8767/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. 

Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries.

According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD.

Further, the report states that the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. 


Key Topics Covered: 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Types of Drugs

08. Geographical Segmentation

09. Key Leading Countries

10. Rate of Incidence and Prevalence

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series


Companies Mentioned:

  • Abbott Laboratories
  • Boston Scientific Corp.
  • Medtronic Inc.
  • Terumo Corp.


For more information visit http://www.researchandmarkets.com/research/tz8767/global


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.